MicroRNAs are potential therapeutic targets in fibrosing kidney disease: Lessons from animal models

Drug Discovery Today: Disease Models

Volumn 10, Issue 3, 2013, Pages

  Duffield, Jeremy S ^a,b   Grafals, Monica ^c,d   Portilla, Didier ^e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^d TUFTS UNIVERSITY   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 21; OLIGONUCLEOTIDE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL COMPARTMENTALIZATION; CHRONIC KIDNEY DISEASE; DRUG BINDING SITE; DRUG TARGETING; EPITHELIUM CELL; FATTY ACID METABOLISM; GENE DELETION; GENE EXPRESSION REGULATION; HUMAN; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY INJURY; KNOCKOUT MOUSE; LEUKOCYTE; MITOCHONDRION; MYOFIBROBLAST; NONHUMAN; PEROXISOME; UPREGULATION;

EID: 84904057633     PISSN: None     EISSN: 17406757     Source Type: Journal    
DOI: 10.1016/j.ddmod.2012.08.004     Document Type: Review

References (43)

1. J.J. Snyder et al. Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004 Am. J. Kidney Dis. 53 2009 218 228
2. R.J. Johnson et al. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension N. Engl. J. Med. 346 2002 913 923
3. Friedman, S.L. et al. Therapy for fibrotic diseases: nearing the start line. Sci. Trans. Med. (in press)
4. Y. Ishii et al. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy Kidney Int. 67 2005 321 332
5. C. Schrimpf, and J.S. Duffield Mechanisms of fibrosis: the role of the pericyte Curr. Opin. Nephrol. Hypertens. 20 2011 297 305
6. A. Ishani et al. Acute kidney injury increases risk of ESRD among elderly J. Am. Soc. Nephrol. 20 2009 223 228
7. R. Lee et al. A short history of a short RNA Cell 116 Suppl. 2004 S89 S92 81 pp. following S96
8. D.V. Dugas, and B. Bartel MicroRNA regulation of gene expression in plants Curr. Opin. Plant Biol. 7 2004 512 520
9. T. Thum et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts Nature 456 2008 980 984
10. B.N. Chau et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways Sci. Transl. Med. 4 2012 121ra118
11. S.A. Melo, and M. Esteller Dysregulation of microRNAs in cancer: playing with fire FEBS Lett. 585 2011 2087 2099
12. P.P. Medina et al. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma Nature 467 2010 86 90
13. P. Gao et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism Nature 458 2009 762 765
14. Y. Cheng et al. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am. J. Pathol. 170 2007 1831 1840
15. B.D. Humphreys et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis Am. J. Pathol. 176 2010 85 97
16. S.L. Lin et al. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney Am. J. Pathol. 173 2008 1617 1627
17. N. Asada et al. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice J. Clin. Invest. 121 2011 3981 3990
18. C.E. Alpers, and K.L. Hudkins Mouse models of diabetic nephropathy Curr. Opin. Nephrol. Hypertens. 20 2011 278 284
19. K.L. Hudkins et al. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy J. Am. Soc. Nephrol. 21 2010 1533 1542
20. B.R. Conway et al. Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy J. Am. Soc. Nephrol. 23 2012 405 411
21. A.P. Castano et al. Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo Sci. Transl. Med. 1 2009 5ra13
22. J.G. Godwin et al. Identification of a microRNA signature of renal ischemia reperfusion injury Proc. Natl. Acad. Sci. U. S. A. 107 2010 14339 14344
23. A. Zarjou et al. Identification of a microRNA signature in renal fibrosis: role of miR-21 Am. J. Physiol. Renal Physiol. 301 2011 F793 F801
24. D. Anglicheau et al. MicroRNA expression profiles predictive of human renal allograft status Proc. Natl. Acad. Sci. U. S. A. 106 2009 5330 5335
25. D.M. Patrick et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice J. Clin. Invest. 120 2010 3912 3916
26. S. Li et al. Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury Kidney Int. 76 2009 1049 1062
27. S. Li et al. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G Am. J. Physiol. Renal Physiol. 287 2004 F990 F998
28. S. Krick et al. Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease Proc. Natl. Acad. Sci. U. S. A. 105 2008 14106 14111
29. N. Kashihara et al. Oxidative stress in diabetic nephropathy Curr. Med. Chem. 17 2010 4256 4269
30. P.S. Modlinger et al. Nitric oxide, oxidative stress, and progression of chronic renal failure Semin. Nephrol. 24 2004 354 365
31. R. Lan et al. PTEN loss defines a TGF-beta-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis Am. J. Physiol. Renal Physiol. 302 2012 F1210 F1223
32. T. O'Bryan et al. Course of renal injury in the Mpv17-deficient transgenic mouse J. Am. Soc. Nephrol. 11 2000 1067 1074
33. M. Clozel et al. Age-dependent hypertension in Mpv17-deficient mice, a transgenic model of glomerulosclerosis and inner ear disease Exp. Gerontol. 34 1999 1007 1015
34. J. Schenkel et al. Functional rescue of the glomerulosclerosis phenotype in Mpv17 mice by transgenesis with the human Mpv17 homologue Kidney Int. 48 1995 80 84
35. H. Weiher et al. Transgenic mouse model of kidney disease: insertional inactivation of ubiquitously expressed gene leads to nephrotic syndrome Cell 62 1990 425 434
36. H.A. Burgess et al. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis Am. J. Physiol. Lung. Cell. Mol. Physiol. 288 2005 L1146 L1153
37. A. Keech et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial Lancet 366 2005 1849 1861
38. S. Putta et al. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy J. Am. Soc. Nephrol. 23 2012 458 469
39. W. Qin et al. TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29 J. Am. Soc. Nephrol. 22 2011 1462 1474
40. S. Volinia et al. Identification of microRNA activity by Targets' Reverse EXpression Bioinformatics 26 2010 91 97
41. P.S. Mitchell et al. Circulating microRNAs as stable blood-based markers for cancer detection Proc. Natl. Acad. Sci. U. S. A. 105 2008 10513 10518
42. A. Zampetaki et al. Profiling of circulating microRNAs: from single biomarkers to re-wired networks Cardiovasc. Res. 93 2012 555 562
43. J. Saikumar et al. Expression, circulation and excretion profile of microRNA-21, -155, and -18a following acute kidney injury Toxicol. Sci. 2012 Jun 15. Epub ahead of print